These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25601896)

  • 1. The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism: A Randomized Clinical Trial.
    Gholami K; Talasaz AH; Entezari-Maleki T; Salarifar M; Hadjibabaie M; Javadi MR; Dousti S; Hamishehkar H; Maleki S
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):483-9. PubMed ID: 25601896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs-CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial.
    Hejazi ME; Modarresi-Ghazani F; Hamishehkar H; Mesgari-Abbasi M; Dousti S; Entezari-Maleki T
    J Clin Pharmacol; 2017 Jan; 57(1):40-47. PubMed ID: 27225617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb.
    Gremmel T; Ay C; Seidinger D; Pabinger I; Panzer S; Koppensteiner R
    J Vasc Surg; 2011 Dec; 54(6 Suppl):48S-55S. PubMed ID: 21890302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population.
    Entezari-Maleki T; Hajhossein Talasaz A; Salarifar M; Hadjibabaie M; Javadi MR; Bozorgi A; Jenab Y; Boroumand MA; Gholami K
    Iran J Pharm Res; 2014; 13(1):319-27. PubMed ID: 24734087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism.
    Bakirci EM; Topcu S; Kalkan K; Tanboga IH; Borekci A; Sevimli S; Acikel M
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):181-5. PubMed ID: 23814171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of soluble P selectin in the diagnosis of venous thromboembolism.
    Antonopoulos CN; Sfyroeras GS; Kakisis JD; Moulakakis KG; Liapis CD
    Thromb Res; 2014 Jan; 133(1):17-24. PubMed ID: 24012101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism.
    Vormittag R; Vukovich T; Schönauer V; Lehr S; Minar E; Bialonczyk C; Hirschl M; Pabinger I
    Thromb Haemost; 2005 Mar; 93(3):488-93. PubMed ID: 15735799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosis.
    Żółciński M; Cieśla-Dul M; Potaczek DP; Undas A
    Thromb Res; 2013 Jul; 132(1):e31-5. PubMed ID: 23791132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
    Jugrin AV; Hösel V; Ustyugova A; De Francesco M; Lamotte M; Sunderland T
    J Med Econ; 2016; 19(1):1-10. PubMed ID: 26390231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
    Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
    Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P- and E- selectin in venous thrombosis and non-venous pathologies.
    Purdy M; Obi A; Myers D; Wakefield T
    J Thromb Haemost; 2022 May; 20(5):1056-1066. PubMed ID: 35243742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
    Bookhart BK; Haskell L; Bamber L; Wang M; Schein J; Mody SH
    J Med Econ; 2014 Oct; 17(10):691-5. PubMed ID: 25065536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial.
    Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM
    Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in lipid metabolism and extension of venous thromboembolism.
    Belaj K; Hackl G; Rief P; Eller P; Brodmann M; Gary T
    Ann Nutr Metab; 2014; 64(2):122-6. PubMed ID: 25012746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.